HeartSciences sells $1M of stock to Fortitude at 22% premium ahead of merger

HeartSciences Inc.

On Aug 12, 2026, Fortitude purchased 411,522 shares at $2.43/share for ~$1.0M in a private placement.
Price is 22% above the $2.43 closing price on purchase date; shares are voting common stock.
Merger exchange ratio unchanged; no extra Fortitude shares issued at closing due to investment.
Fortitude now holds ~9.4% of HeartSciences outstanding common stock.
Proceeds add working capital ahead of proposed merger close expected in H2 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.